Shanshan Wang

Dr. Shanshan Wang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2026 in Measurement
Verified
Journal Article
Closed access
XHXiali Han
Xiali Han
SWShanshan Wang
Shanshan Wang
JYJianding Yu
Jianding Yu
PWPengjun Wang
Pengjun Wang
XLXiangyu Li
Xiangyu Li

1 October 2023 in International Immunopharmacology
Verified
Journal Article
Open access
XLXin Li
Xin Li
LHLun He
Lun He
YOYanhua Ou
Yanhua Ou
SWShanshan Wang
Shanshan Wang
YHYaqian Hu
Yaqian Hu
HNHai-Tao Niu
Hai-Tao Niu
Oxymatrine, also known as ammothamnine or oxysophoridine, is a natural compound isolated from Sophora flavescens (in Chinese, Kushen), and many previous researchers have characterized its anti-inflammatory, anti-fibrotic and anti-tumor properties. However, the underlying anti-tumor immunological mechanism of oxymatrine remains elusive. In this study, we carried out experiments both in vitro and in vivo and investigated the anti-tumor effect of oxymatrine to inhibit the proliferation and migration of melanoma B16 cells, while promoting apoptosis. Oxymatrine upregulated CD4+ T, CD8+ T and NKT cells, downregulated Treg cells, promoted TNF-α secretion, and successfully modulated the immune microenvironment and ultimately suppressed melanoma development in subcutaneous tumor models established in mice. Evidence from network pharmacology and RNAseq suggested that possible targets of oxymatrine for melanoma treatment included PD-L1 and MYC. We observed oxymatrine inhibited PD-L1 and MYC expression in melanoma cells via qRT-PCR and western blotting analysis, and found MYC potentially regulated PD-L1 to mediate anti-tumor effects. These findings provide insight into the mechanism by which oxymatrine inhibits melanoma and enhances the anti-tumor immune effect. In summary, our study proposes a novel approach to suppress melanoma by targeting the MYC/PD-L1 pathway using oxymatrine, which may develop into a less toxic and more efficient anti-tumor agent for melanoma treatment.

30 March 2026 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
SWShanshan Wang
Shanshan Wang
XZXiaowei Zhang
Xiaowei Zhang
PWPengjun Wang
Pengjun Wang
XLXiangyu Li
Xiangyu Li
This paper proposes a physically unclonable function (PUF) design method based on a magnetic sensor array, leveraging inherent process variations in sensor manufacturing as an entropy source to generate unique cryptographic keys without requiring additional hardware support. This approach reduces system complexity while enhancing security. A balancing algorithm and reconfigurable strategy are employed to optimize PUF responses and improve stability. Furthermore, a lightweight bidirectional authentication protocol based on the magnetic sensor array PUF is introduced, with formal analysis demonstrating its effectiveness in resisting common security threats, including man-in-the-middle attacks, replay attacks, and brute-force attacks. Experimental results show that the proposed PUF exhibits excellent uniqueness, randomness, and reliability, achieving a randomness of 98% and a reliability of 97.8%. Compared to conventional silicon-based PUFs, this approach offers advantages such as low cost, low power consumption, and high environmental adaptability, providing an efficient and secure identity authentication and data protection solution for resource-constrained IoT devices.

25 January 2026 in Measurement
Verified
Journal Article
Closed access
SWShanshan Wang
Shanshan Wang
HYHuijing Yang
Huijing Yang
GJGan Jiao
Gan Jiao
MRMingyuan Ren
Mingyuan Ren
XLXiangyu Li
Xiangyu Li

5 December 2014
Verified
Book Chapter
Closed access
PDF file
HZHong Zhu
Hong Zhu
JZJunhai Zhai
Junhai Zhai
SWShanshan Wang
Shanshan Wang
XWXizhao Wang
Xizhao Wang

7 October 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
SLShuyi Lu
Shuyi Lu
QWQian Wu
Qian Wu
SWShanshan Wang
Shanshan Wang
DSDongru Sun
Dongru Sun
YLYan Liu
Yan Liu
BHBiling Huang
Biling Huang